{"DataElement":{"publicId":"2704246","version":"1","preferredName":"HLA-DP Antigen First Antigen  Name","preferredDefinition":"A description of the 1st HLA-DP antigen.","longName":"HLADP_1ST_ANTGN_NME","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2704240","version":"1","preferredName":"HLA-DP Antigen First Antigen","preferredDefinition":"HLA-DP antigen is a class of glycoproteins that consist of dimers of alpha and beta subunits, which are encoded by the polymorphic human genes HLA-DPA1 and HLA-DPB1, respectively. This protein complex is expressed primarily in lymphoid cells and function to present antigens for CD4+ T lymphocytes. _Preceding all others in time or space or degree._Any substance, generally a protein, that stimulates the immune system and elicits an immune response.  Recognition by the immune system elicits either a T-lymphocyte response, recognizing processed antigens, or a B-lymphocyte response, producing antibodies that bind to unprocessed antigens.","longName":"HLADP_1ST_ANTGN","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2704193","version":"1","preferredName":"HLA-DP Antigen\r\n","preferredDefinition":"HLA-DP antigen is a class of glycoproteins that consist of dimers of alpha and beta subunits, which are encoded by the polymorphic human genes HLA-DPA1 and HLA-DPB1, respectively. This protein complex is expressed primarily in lymphoid cells and function to present antigens for CD4+ T lymphocytes.\r\n","longName":"C71274","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HLA-DP Antigen","conceptCode":"C71274","definition":"HLA-DP antigen is a class of glycoproteins that consist of dimers of alpha and beta subunits, which are encoded by the polymorphic human genes HLA-DPA1 and HLA-DPB1, respectively. This protein complex is expressed primarily in lymphoid cells and function to present antigens for CD4+ T lymphocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"40142F18-1224-39F8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-29","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-11-29","modifiedBy":"ONEDATA","dateModified":"2007-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2695121","version":"1","preferredName":"First Antigen","preferredDefinition":"Preceding all others in time or space or degree.:Any substance that appears foreign or potentially adverse to the body and elicits immune response.","longName":"C25509:C268","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"First","conceptCode":"C25509","definition":"Preceding all others in time or space or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Antigen","conceptCode":"C268","definition":"Any substance, generally a protein, that stimulates the immune system and elicits an immune response.  Recognition by the immune system elicits either a T-lymphocyte response, recognizing processed antigens, or a B-lymphocyte response, producing antibodies that bind to unprocessed antigens.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3ED01EDB-2CA6-5890-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-13","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-11-13","modifiedBy":"ONEDATA","dateModified":"2007-11-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4013FFD1-F9E9-5A93-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-29","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-11-29","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2704229","version":"1","preferredName":"HLA-DP Antigen Name","preferredDefinition":"HLA-DP antigen is a class of glycoproteins that consist of dimers of alpha and beta subunits, which are encoded by the polymorphic human genes HLA-DPA1 and HLA-DPB1, respectively. This protein complex is expressed primarily in lymphoid cells and function to present antigens for CD4+ T lymphocytes._The words or language units by which a thing is known.","longName":"HLADP_ANTGN_NME","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"DPw1","valueDescription":"DPw1 Antigen","ValueMeaning":{"publicId":"2704230","version":"1","preferredName":"DPw1 Antigen","longName":"2704230","preferredDefinition":"DPw1 Antigen by Serologic Typing","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4013E6CF-7D24-594C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2007-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4013E6CF-7D3D-594C-E044-0003BA3F9857","beginDate":"2007-06-08","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-11-29","modifiedBy":"ALEYR","dateModified":"2007-11-29","deletedIndicator":"No"},{"value":"DPw2","valueDescription":"DPw2 Antigen","ValueMeaning":{"publicId":"2704231","version":"1","preferredName":"DPw2 Antigen","longName":"2704231","preferredDefinition":"DPw2 Antigen by Serologic Typing","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4013E6CF-7D49-594C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2007-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4013E6CF-7D62-594C-E044-0003BA3F9857","beginDate":"2007-06-08","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-11-29","modifiedBy":"ALEYR","dateModified":"2007-11-29","deletedIndicator":"No"},{"value":"DPw3","valueDescription":"DPw3 Antigen","ValueMeaning":{"publicId":"2704232","version":"1","preferredName":"DPw3 Antigen","longName":"2704232","preferredDefinition":"DPw3 Antigen by Serologic Typing","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4013E6CF-7D6E-594C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2007-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4013E6CF-7D87-594C-E044-0003BA3F9857","beginDate":"2007-06-08","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-11-29","modifiedBy":"ALEYR","dateModified":"2007-11-29","deletedIndicator":"No"},{"value":"DPw4","valueDescription":"DPw4 Antigen","ValueMeaning":{"publicId":"2704233","version":"1","preferredName":"DPw4 Antigen","longName":"2704233","preferredDefinition":"DPw4 Antigen by Serologic Typing","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4013E6CF-7D93-594C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2007-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4013E6CF-7DAC-594C-E044-0003BA3F9857","beginDate":"2007-06-08","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-11-29","modifiedBy":"ALEYR","dateModified":"2007-11-29","deletedIndicator":"No"},{"value":"DPw5","valueDescription":"DPw5 Antigen","ValueMeaning":{"publicId":"2704234","version":"1","preferredName":"DPw5 Antigen","longName":"2704234","preferredDefinition":"DPw5  Antigen by Serologic Typing","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4013E6CF-7DB8-594C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2007-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4013E6CF-7DD1-594C-E044-0003BA3F9857","beginDate":"2007-06-08","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-11-29","modifiedBy":"ALEYR","dateModified":"2007-11-29","deletedIndicator":"No"},{"value":"DPw6","valueDescription":"DPw6 Antigen","ValueMeaning":{"publicId":"2704235","version":"1","preferredName":"DPw6 Antigen","longName":"2704235","preferredDefinition":"DPw6 Antigen by Serologic Typing","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4013E6CF-7DDD-594C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2007-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4013E6CF-7DF6-594C-E044-0003BA3F9857","beginDate":"2007-06-08","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-11-29","modifiedBy":"ALEYR","dateModified":"2007-11-29","deletedIndicator":"No"},{"value":"DPX","valueDescription":"DPX Antigen","ValueMeaning":{"publicId":"2704236","version":"1","preferredName":"DPX Antigen","longName":"2704236","preferredDefinition":"DPX Antigen by Serologic Typing","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4013E6CF-7E02-594C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2007-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4013E6CF-7E1B-594C-E044-0003BA3F9857","beginDate":"2007-06-08","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-11-29","modifiedBy":"ALEYR","dateModified":"2007-11-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2704228","version":"1","preferredName":"HLA-DP Antigen\r\n Name","preferredDefinition":"HLA-DP antigen is a class of glycoproteins that consist of dimers of alpha and beta subunits, which are encoded by the polymorphic human genes HLA-DPA1 and HLA-DPB1, respectively. This protein complex is expressed primarily in lymphoid cells and function to present antigens for CD4+ T lymphocytes.\r\n:The words or language units by which a thing is known.","longName":"C71274:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HLA-DP Antigen","conceptCode":"C71274","definition":"HLA-DP antigen is a class of glycoproteins that consist of dimers of alpha and beta subunits, which are encoded by the polymorphic human genes HLA-DPA1 and HLA-DPB1, respectively. This protein complex is expressed primarily in lymphoid cells and function to present antigens for CD4+ T lymphocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4013E6BA-6511-5769-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-29","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-11-29","modifiedBy":"ONEDATA","dateModified":"2007-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4013E6BA-6522-5769-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-08","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-11-29","modifiedBy":"KUMMEROA","dateModified":"2019-06-05","changeDescription":". Removed extra :_\" at end of sentence. AK 6/5/19","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964909","version":"1","longName":"2005r1: Confirmation of HLA Typing","context":"NHLBI"}]},{"publicId":"2842777","version":"1","longName":"Labs","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2859958","version":"1","longName":"HLA Typing","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"hla_srlgy_num_1_dp_atg_sp","type":"NMDP_FN","context":"NHLBI"},{"name":"PerformedClinicalResult:value","type":"HCT_BRIDG","context":"NHLBI"},{"name":"hla_option_DP_1st_antigen_name","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"First DP antigen specificity:","type":"Preferred Question Text","description":"First DP antigen specificity:","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:2704246","type":"BRIDG Mapping Path","description":"PerformedClinicalResult.value(ANY=>CD) WHERE PerformedClinicalResult > PerformedObservation > DefinedObservation.nameCode = \"test for HLA-DP Antigen\" AND PerformedClinicalResult.targetAnatomicSiteCode = \"First Allele\"","url":null,"context":"NHLBI"},{"name":"Specificity - 1st antigen","type":"Alternate Question Text","description":"Specificity - 1st antigen","url":null,"context":"NHLBI"},{"name":"Specificity - 1st antigen","type":"Application Standard Question Text","description":"Specificity - 1st antigen","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"40150DE1-650C-5E00-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-11-29","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-11-29","modifiedBy":"ALEYR","dateModified":"2019-04-07","changeDescription":". 4/21/10mn-alt name 'type' was wrong: nci_mo_code - changed to ndmp_fn Added alt name and Application SQT for 2005. AK 8/11/13 Added human readable def. System generated def displayed as alt def. No version needed. AK 10/24/14","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}